{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:25:52Z","timestamp":1761236752170},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1016\/0959-8049(95)00619-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:46:22Z","timestamp":1027619182000},"page":"814-820","source":"Crossref","is-referenced-by-count":84,"title":["Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial"],"prefix":"10.1016","volume":"32","author":[{"given":"C.","family":"Viscoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garaventa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Giacchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Congiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(95)00619-2_BIB1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0025-7125(16)32514-7","article-title":"Infectious complications of neoplastic disease","volume":"55","author":"Armstrong","year":"1971","journal-title":"Med Clin North Am"},{"issue":"Suppl. 1","key":"10.1016\/0959-8049(95)00619-2_BIB2","first-page":"s35","article-title":"Empiric antimicrobial therapy for febrile, granulocytopenic cancer patients: lessons from 4 EORTC trials","volume":"24","author":"Klastersky","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/0959-8049(95)00619-2_BIB3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0959-8049(95)00619-2_BIB6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0889-8588(18)30215-6","article-title":"Management of immunocompromised patients with evidence of invasive mycosis","volume":"5","author":"Walsh","year":"1993","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/0959-8049(95)00619-2_BIB7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF01961853","article-title":"Efficacy of fluconazole in the treatment of systemic fungal infections","volume":"11","author":"Milatovic","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/0959-8049(95)00619-2_BIB8","first-page":"19","article-title":"Fluconazole treatment of fungal infections in the immunocompromised host","volume":"17","author":"Meunier","year":"1990"},{"key":"10.1016\/0959-8049(95)00619-2_BIB9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-120-11-199406010-00003","article-title":"Preventing fungal infection in granulocytopenic patients with acute leukemia: fluconazole compared with oral Amphotericin B","volume":"120","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB12","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and granulocytopenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB13","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infection with fluconazole prophylaxis in granulocytopenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0959-8049(95)00619-2_BIB14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/161.3.397","article-title":"The design, analysis and reporting of clinical trials on the empirical antibiotic management of the granulocytopenic patient","volume":"161","author":"Consensus Panel of the Immunocompromised Host Society","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/0959-8049(95)00619-2_BIB15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0021-9681(66)90066-X","article-title":"Fungal infections complicating acute leukemia","volume":"19","author":"Bodey","year":"1966","journal-title":"J Chronic Dis"},{"key":"10.1016\/0959-8049(95)00619-2_BIB16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/1097-0142(197208)30:2<348::AID-CNCR2820300207>3.0.CO;2-O","article-title":"Fungal infection in acute leukemia","volume":"30","author":"Mirsky","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00619-2_BIB17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ajcp\/68.1.29","article-title":"Disseminated candidiasis. Changes in incidence, underlying disease and pathology","volume":"68","author":"Myerwitz","year":"1977","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/0959-8049(95)00619-2_BIB18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-86-5-539","article-title":"Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response","volume":"86","author":"Aisner","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB19","first-page":"1","article-title":"The clinical significance and management of fever in acute myelocytic leukemia","volume":"139","author":"Burke","year":"1976","journal-title":"John Hopkins Med J"},{"key":"10.1016\/0959-8049(95)00619-2_BIB20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB21","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/0959-8049(95)00619-2_BIB22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.1992.10.2.316","article-title":"Risk assessment in cancer patients with fever and neutropenia: a prospective, twocenter validation of a prediction rule","volume":"10","author":"Talcott","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00619-2_BIB23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0959-8049(94)90412-X","article-title":"Factors associated bacteraemia in febrile, granulocytopenic cancer patients","volume":"30A","author":"Viscoli","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/0959-8049(95)00619-2_BIB24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/clinids\/18.4.525","article-title":"Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis","volume":"18","author":"Guiot","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/0959-8049(95)00619-2_BIB25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1994.12.4.827","article-title":"Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin B prophylaxis in high-risk patients","volume":"12","author":"O'Donnell","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00619-2_BIB26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/clinids\/18.5.793","article-title":"Editorial response: evolving risk factors for invasive fungal infections\u2014All neutropenic patients are not the same","volume":"18","author":"Walsh","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/0959-8049(95)00619-2_BIB27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1128\/AAC.35.2.365","article-title":"Fluconazole in the treatment of candidiasis in immunocompromised children","volume":"35","author":"Viscoli","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0959-8049(95)00619-2_BIB28","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/JCM.32.9.2092-2098.1994","article-title":"Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection","volume":"32","author":"Ruhnke","year":"1994","journal-title":"J Clin Microbiol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804995006192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804995006192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T17:54:25Z","timestamp":1579024465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0959804995006192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["0959804995006192"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(95)00619-2","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}